Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 91 AL 105

Mitochondrial mechanisms in Alzheimer's disease: Quest for therapeutics

Kalani K, Chaturvedi P, Chaturvedi P, Kumar Verma V, Lal N, Awasthi SK, Kalani A.

Drug Discov Today. 2023 May;28(5):103547. doi: 10.1016/j.drudis.2023.103547. Epub 2023 Mar 5.

Cellular response to β-amyloid neurotoxicity in Alzheimer's disease and implications in new therapeutics

Zhang H, Li X, Wang X, Xu J, Elefant F, Wang J.

Animal Model Exp Med. 2023 Feb;6(1):3-9. doi: 10.1002/ame2.12313.

The past and present of therapeutic strategy for Alzheimer's diseases: potential for stem cell therapy

Murayama MA.

Exp Anim. 2023 Aug 7;72(3):285-293. doi: 10.1538/expanim.22-0164. Epub 2023 Mar 6.

Esmethadone-HCl (REL-1017): a promising rapid antidepressant

Fava M, Stahl SM, De Martin S, Mattarei A, Bettini E, Comai S, Alimonti A, Bifari F, Pani L, Folli F, Guidetti C, Furlan A, Sgrignani J, Locatelli P, Cavalli A, O'Gorman C, Traversa S, Inturrisi CE, Pappagallo M, Manfredi PL.

Eur Arch Psychiatry Clin Neurosci. 2023 Oct;273(7):1463-1476. doi: 10.1007/s00406-023-01571-4. Epub 2023 Mar 8.

HSV-1 cellular model reveals links between aggresome formation and early step of Alzheimer's disease

Albaret MA, Textoris J, Dalzon B, Lambert J, Linard M, Helmer C, Hacot S, Ghayad SE, Ferréol M, Mertani HC, Diaz JJ.

Transl Psychiatry. 2023 Mar 10;13(1):86. doi: 10.1038/s41398-023-02376-8.

Using Optogenetics to Model Cellular Effects of Alzheimer's Disease

Tiwari P, Tolwinski NS.

Int J Mol Sci. 2023 Feb 21;24(5):4300. doi: 10.3390/ijms24054300.

Aducanumab-Hope or Disappointment for Alzheimer's Disease

Wojtunik-Kulesza K, Rudkowska M, Orzeł-Sajdłowska A.

Int J Mol Sci. 2023 Feb 22;24(5):4367. doi: 10.3390/ijms24054367.

Natural Alkaloids as Multi-Target Compounds towards Factors Implicated in Alzheimer's Disease

Vrabec R, Blunden G, Cahlíková L.

Int J Mol Sci. 2023 Feb 23;24(5):4399. doi: 10.3390/ijms24054399.

The Effects of Momordica charantia on Type 2 Diabetes Mellitus and Alzheimer's Disease

Richter E, Geetha T, Burnett D, Broderick TL, Babu JR.

Int J Mol Sci. 2023 Feb 28;24(5):4643. doi: 10.3390/ijms24054643.

Status of Metabolomic Measurement for Insights in Alzheimer's Disease Progression-What Is Missing?

Yin C, Harms AC, Hankemeier T, Kindt A, de Lange ECM.

Int J Mol Sci. 2023 Mar 4;24(5):4960. doi: 10.3390/ijms24054960.

Cell Membrane Biomimetic Nanoparticles with Potential in Treatment of Alzheimer's Disease

Zhong X, Na Y, Yin S, Yan C, Gu J, Zhang N, Geng F.

Molecules. 2023 Mar 3;28(5):2336. doi: 10.3390/molecules28052336.

Oxidative stress: A target to treat Alzheimer's disease and stroke

Briyal S, Ranjan AK, Gulati A.

Neurochem Int. 2023 May;165:105509. doi: 10.1016/j.neuint.2023.105509. Epub 2023 Mar 11.

[Lecanemab in Alzheimer's disease: are we really before a shift in the prognosis of the disease?]

Pérez-Martínez DA.

Rev Neurol. 2023 Mar 16;76(6):185-188. doi: 10.33588/rn.7606.2023055.

Study protocol for a phase III randomised controlled trial of Sailuotong (SLT) for vascular dementia and Alzheimer's disease with cerebrovascular disease

Karamacoska D, Chan DKY, Leung I, Liu JX, Brodaty H, Fahey PP, Bensoussan A, Chang DH.

PLoS One. 2023 Mar 15;18(3):e0265285. doi: 10.1371/journal.pone.0265285. eCollection 2023.

Engineered mesenchymal stem cell-derived extracellular vesicles: A state-of-the-art multifunctional weapon against Alzheimer's disease

Yin T, Liu Y, Ji W, Zhuang J, Chen X, Gong B, Chu J, Liang W, Gao J, Yin Y.

Theranostics. 2023 Feb 5;13(4):1264-1285. doi: 10.7150/thno.81860. eCollection 2023.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias